Intellectual Property India Publishes Patent Application for Processes For Making Intermediates For Isoindolinone Inhibitors Of The Mdm2-P53 Interaction Having Anticancer Activity

MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202617070173 A) filed by Otsuka Pharmaceutical Co. , Ltd. on June 04, 2026, for Processes For Making Intermediates For Isoindolinone Inhibitors Of The Mdm2-P53 Interaction Having Anticancer Activity.

Inventors include Shakya, Sagar; Johnson, Matt; Wong, Nicholas; Bodhuri, Prabhudas Number; and Davar, Nipun.

The application for the patent was published on July 03, 2026, under issue no. 27/2026.

Abstract: The present disclosure relates to processes for preparing synthetic intermediates for the synthesis of isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity.

Disclaimer: Curated by HT Syndication.